Explore chapters and articles related to this topic
Micafungin
Published in M. Lindsay Grayson, Sara E. Cosgrove, Suzanne M. Crowe, M. Lindsay Grayson, William Hope, James S. McCarthy, John Mills, Johan W. Mouton, David L. Paterson, Kucers’ The Use of Antibiotics, 2017
Nicholas D. Beyda, Russell E. Lewis, Dimitrios P. Kontoyiannis
Micafungin lacks clinically meaningful activity against basidiomycetes, including Trichosporon, Crypto-coccus neoformans, and Cryptococcus gattii, even though they possess a beta-glucan synthase enzyme which is sensitive to echinocandin inhibition (Maligie and Selitrennikoff, 2005). The inherent resistance observed in these fungi is thought to be a result of compensatory stress response pathways (e.g., protein kinase C and calcineurin), multidrug efflux pumps, melanin, and/or drug degradation pathways (Maligie and Selitrennikoff, 2005). While scarce, a limited number of in vitro and animal model studies have demonstrated that micafungin in combination with amphotericin B or azole can be synergistic against Cryptococcus and Trichosporon asahii (Serena AAC 2005a, 2005b). However, micafungin monotherapy should not be considered a viable treatment option for infections caused by these species.
Infections and infestations affecting the nail
Published in Eckart Haneke, Histopathology of the NailOnychopathology, 2017
Cryptococcus neoformans is a saprophyte basidiomycete found worldwide in soil and pigeon droppings. Cryptococcus gattii is mainly found in the tropics. It is an opportunistic yeast causing invasive infections mainly in immunodepressed individuals, such as HIV infection, high-dose corticosteroid therapy and advanced cancer,300 and after organ transplantation.301–303 Fever and meningitis not responding to antibacterial antibiotics are the main clinical presentations.304 However, skin and nail involvement occurs in 10%–15% of patients with systemic cryptococcosis and primary cutaneous cryptococcosis occasionally occurs in solid organ transplant recipients, but also in otherwise healthy individuals, particularly after a minor trauma.305–307 Cutaneous cryptococcosis of the great toe was observed to precede systemic disease for several months.308 In the hand, tenosynovitis and osteomyelitis were observed.309 Skin lesions are usually very variable and nonspecific.310,311 There was severe ulcerating paronychia in a case of a cryptococcus nail unit infection and a hemorrhagic whitlow in another immunocompetent patient.312–314
Fungal infections in lung transplantation
Published in Wickii T. Vigneswaran, Edward R. Garrity, John A. Odell, LUNG Transplantation, 2016
Cryptococcus is an encapsulated yeast that is often found in soil contaminated with bird droppings. Of the 37 species included in the genus, only 2 cause human disease: Cryptococcus neoformans which is distributed worldwide, and Cryptococcus gattii, which can be acquired in the Pacific Northwest in both Canada and the United States, as well as in some parts of Africa and Australia.115
Clinical characteristics and evaluation of the incidence of cryptococcosis in Finland 2004–2018
Published in Infectious Diseases, 2021
Anne Toivonen, Mari Eriksson, Nathalie Friberg, Timo Hautala, Sohvi Kääriäinen, Jaana Leppäaho-Lakka, Janne Mikkola, Tuomas Nieminen, Jarmo Oksi, Juha H. Salonen, Pekka Suomalainen, Markku Vänttinen, Hanna Jarva, Annemarjut J. Jääskeläinen
Encapsulated Cryptococcus neoformans and Cryptococcus gattii are the most common cryptococcal opportunistic fungal pathogens in humans [1]. The majority of cryptococcal infections worldwide are caused by C. neoformans, which occurs in most temperate regions whereas C. gattii has been found mainly in tropical and subtropical geographic regions [1,2]. Cryptococcus is transmitted by inhalation of infectious cells followed by an infection of the respiratory system. The pulmonary infection may disseminate by haematogenous route and further affect the central nervous system (CNS) causing meningoencephalitis [1]. The infection may also manifest as cryptococcemia, though the most common clinical features are meningoencephalitis and pulmonary cryptococcosis [3]. Moreover, a disseminated cryptococcal infection associates with higher mortality compared to respiratory disease [4]. However, the variable nature of clinical presentations may delay the diagnosis.
Advances in the diagnosis of fungal pneumonias
Published in Expert Review of Respiratory Medicine, 2020
Bryan T. Kelly, Kelly M. Pennington, Andrew H. Limper
Aside from endemic fungi, Candida and Cryptococcus spp. are the most common yeast forms to cause invasive disease. Candida spp. is a very rare cause of pulmonary infection and more typically causes catheter-related bloodstream and deep-tissue infections. Cryptococcus neoformans and Cryptococcus gattii are the main pathogenic Cryptococcal species causing disease in humans. The primary route of infection is through the respiratory tract, and dissemination, particularly to the CNS, is common amongst immunocompromised hosts. Diagnosis of pulmonary Cryptococcosis may be challenging owing to the varying presentation, which may be mild or asymptomatic.